Research

Nourishing Networks in Neuroscience

Building Trust, Enabling Precision

We empower comprehensive analyses of behavior and biology in neurodegenerative and neuropsychological disorders. Our patient-centric approach means our staff can routinely cultivate the trust needed to collect the diverse sample and data types needed for studying these complex diseases. As an end-to-end service solution provider, we streamline logistics to save you time and resources, while maximizing your project’s potential.

  • Alzheimer’s Disease (AD)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Bipolar Disorder
  • Depression
  • Epilepsy
  • General Anxiety Disorder
  • Insomnia
  • Myasthenia Gravis
  • Multiple Sclerosis
  • Parkinson’s Disease (PD)

Sanguine's Expertise in Neurodegeneration & Neuropsychology

>1,500

Patient Members

>25

Studies Completed

NEUROPSYCHOLOGY & NEURODEGENERATION - Map

Contact us to discuss your research needs

Sanguine Services

  • Whole Blood
  • Serum
  • Plasma
  • Urine
  • Skin Taping
  • DNA/RNA
  • PBMCs (+ Derivatives)
  • Hair
  • Stool
  • Semen
  • Nails
  • Buffy Coat
  • PBMC isolation
  • Urine processing
  • Serum and plasma isolation
  • Flare events (eg: Multiple sclerosis)
  • Remission
  • Active disease
  • Stage (early, middle, late)
  • Disease Confirmation
  • Covid-19 (PCR)
  • Sickle Cell
  • HIV/HPV/Hepatitis/Herpes Etc.
  • BioMarker Quantification
  • CBC, Platelett, & Diff
  • CRP
  • Cal-Protecin
  • ANA
  • Cytokine Panel
  • BUN
  • Urinalysis
  • Thyroid Stimulating Hormone
  • Lipid Panel
  • LDH
  • Genetic Analysis
  • HLA Typing
  • dsDNA
  • RNA Vial Load Qaunitification
  • HBV Genotyping
  • SLEDAI scoring
  • CDAI (Crohn's)
  • DAS-28 (RA)
  • SF-36
  • HAQ-DI
  • FACIT
  • Bristol Scoring
  • PRO
  • Medical Records
  • Demographics
  • DAS (spell out)
  • Flare events
  • Longitudinal
  • "Multicohort--> Similar mechanism (e.g. diseases of the complement pathway)"
  • ALSFER Score

The emergence of new experimental therapies suggests the pace of clinical advancement may finally increase for neurodegenerative and neuropsychological conditions. We offer a single point of access to a nationwide growing community of patients living with these conditions, reachable through our mobile fleet of phlebotomists. Our in-home capabilities include minimally invasive biospecimens and data collection, all sourced from highly annotated patients who routinely engage with us. Through direct relationships with them and their caregivers, we create new opportunities and unique perspectives for the pharmaceutical industry within this high-risk, high-reward field.

on-demand-webinar
ON-DEMAND WEBINAR

How the Direct-to-Patient Approach Can Streamline your Research Study and Trials

Translational-Research
ON THE BLOG

Considerations for Feasibility in Translational Research

Hear From Our Community

Kaley-Neuro1-@2x

" I love knowing that Sanguine puts patients first and genuinely cares about improving our quality of life. I participate in multiple sclerosis research that Sanguine supports because of their commitment to patient wellness and their laser-sharp focus on research that will truly move the needle for our quality of life."

Kaley

email

Subscribe to our Newsletter

Select what you would like to receive directly in your email